Cheng Zhan

48PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|May 10, 2026
Targeting UXS1-Dependent Glucuronate Detoxification Potentiates Metformin's Anti-Tumor Efficacy in Lung Adenocarcinoma.

|Apr 20, 2026
Unveiling DEFB1 as a novel driver and promising therapeutic target in lung adenocarcinoma.

|Nov 11, 2025
Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status.

Yunyi Bian, Guangyao Shan, Guoshu Bi

|Oct 14, 2025
CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancer.

Jiaqi Liang, Guoshu Bi, Xiaolong Huang

|Oct 07, 2025
Ferroptosis-induced SUMO2 lactylation counteracts ferroptosis by enhancing ACSL4 degradation in lung adenocarcinoma.

Guangyao Shan, Yunyi Bian, Qihai Sui

|Sep 02, 2025
Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC.

Guoshu Bi, Jiaqi Liang, Yunyi Bian

Pageof 8

Frequent Collaborators

14 joint publications

Qun Wang

7 joint publications

Guoshu Bi

7 joint publications

Jiaqi Liang

5 joint publications

Guangyao Shan